Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Optical Coherence Tomography and Glaucoma Progression: A Comparison of a Region of Interest Approach to Average Retinal Nerve Fiber Layer Thickness

Thenappan, Abinaya BA*; De Moraes, Carlos Gustavo MD, MPH; Wang, Diane L. BA*; Xin, Daiyan PhD*; Jarukasetphon, Ravivarn MD; Ritch, Robert MD; Hood, Donald C. PhD*,†

doi: 10.1097/IJG.0000000000000654
Original Studies
Buy

Purpose: To determine whether the change in the retinal nerve fiber layer (RNFL) thickness in a region of interest (ROI) is a better measure of glaucoma progression than the change in average circumpapillary (cp) RNFL thickness.

Methods: Disc cube scans were obtained with frequency domain optical coherence tomography from 60 eyes of 60 patients (age, 61.7±12.7 y) with early or suspected glaucoma and controlled intraocular pressure. The average time between 2 test dates was 3.2±1.8 years. En-face images of the scans from the 2 tests were aligned based on the blood vessels, and cp images were derived for an annulus 100 μm wide and 3.4 mm in diameter, centered on the disc. An ROI was defined as the portion of the circumpapillary retinal nerve fiber layer (cpRNFL) plot within the temporal disc that extended below the 1% confidence interval for ≥5 degrees. Trend analysis using multilevel mixed-effects models was used to compare the rates of change between ROI width and average cpRNFL thickness.

Results: In total, 26 of the 60 eyes had a total of 33 ROIs. The ROI width significantly increased between the 2 test dates (median, 4.9 degrees; Q1=1.03 degrees, Q3=10.5 degrees). In comparison, the average cpRNFL thickness did not decrease significantly over the same period (median, −0.7 μm; Q1=−2.7 μm, Q3=2.7 μm). Mixed-effects linear models confirmed significant ROI progression (P=0.015), but not average cpRNFL (P=0.878).

Conclusions: In this population, RNFL thinning in a ROI is a better measure of progression than is average cpRNFL thickness change.

*Department of Psychology, Columbia University

Department of Ophthalmology, Columbia University

Einhorn Clinical Research Center, New York Eye and Ear Infirmary of Mount Sinai, New York, NY

Supported by National Institutes of Health Grant R01-EY-02115 (D.C.H.), R01-EY-025253 (C.G.D.M.), and Lary Stromfeld Research Fund of NYEEI (R.R. and R.J.).

Disclosure: D.C.H.—Topcon Medical Systems Inc. (Financial support, consultant). The remaining authors declare no conflict of interest.

Reprints: Donald C. Hood, PhD, Department of Psychology, Columbia University, 406 Schermerhorn Hall, 1190 Amsterdam Avenue, MC 5501, New York, NY 10027 (e-mail: dch3@columbia.edu).

Received October 22, 2016

Accepted January 25, 2017

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.